|Bid||67.990 x 800|
|Ask||68.000 x 800|
|Day's Range||67.840 - 69.480|
|52 Week Range||60.140 - 84.000|
|PE Ratio (TTM)||10.41|
|Earnings Date||Aug 8, 2018|
|Forward Dividend & Yield||2.00 (2.85%)|
|1y Target Est||86.80|
Shares of CVS Health jump after a federal judge allows AT&T's bid for Time Warner to go forward. The ruling is seen as a tacit go-ahead for so-called vertical mergers. CVS Health confirmed the pending deal for Aetna in December, a transaction valued at...
Zacks Industry Outlook Highlights: Becton and Dickinson, Johnson & Johnson, Cigna and CVS Health
The Jun. 12 U.S. District Court decision to allow AT&T Inc. (NYSE:T) to buy Time Warner Inc (NYSE:TWX) for $85 billion just set the table for more big M&A deals in the second half of the year. Acquisitions already in the works, such as CVS Health Corp (NYSE:CVS) buying Aetna Inc (NYSE:AET) for $69 billion, likely have clear sailing as a result of the decision. The Fed is likely to announce an interest rate hike 0.25% late Wednesday with speculation it might boost rates four times this year instead of the three forecasted.
CVS Health Corporation (NYSE:CVS) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In theRead More...
While the world focused on the shares of media companies after a federal judge approved AT&T's (T) proposed $85 billion acquisition of Time Warner (TWX), other industries also benefited from the prospects of mega-deals. As Barron's Varada Bhat wrote, the S&P 500's top-performing stocks on Wednesday were either already involved in merger activities, or those that might be. Pharmacy chain CVS Health (CVS) announced plans to acquire Aetna (AET) for $69 billion in December.
RICHMOND, Va., June 14, 2018 /PRNewswire/ -- CVS Health (CVS) announced today that the company has expanded its safe medication disposal program to select CVS Pharmacy locations in Virginia to help facilitate proper and timely disposal of opioids and other medications that could be diverted or misused if left in medicine cabinets.
Fred's Inc. said on June 14, 2018 that it has hired an investment bank "to analyze the value of (its) retail pharmacy script portfolio" and "engage with potential strategic buyers. There’s been some speculation CVS Health, Walgreens Boots Alliance and the company that will be created once Rite Aid and Albertsons complete their merger could be interested in some of Fred’s properties. Fred’s has already sold its specialty pharmacy business to CVS for $40 million.
FILE: The CVS Health Corp. signage is displayed outside a pharmacy store in downtown Los Angeles, California, U.S., on Friday, Oct. 27, 2017. It’s been a good week for CVS Health and Aetna with a judge clearing the AT&T-Time Warner merger and now the nation’s largest doctor group staying quiet on the drugstore chain’s proposed acquisition of the nation’s third-largest health insurance company. Wall Street is cheering a federal judge’s ruling that the U.S. Justice Department failed to prove that AT&T’s $85 billion purchase of Time Warner violated antitrust deals.
A firm offer from Comcast, widely expected later in the day, could upend Fox's $52 billion all-stock deal to be bought by Walt Disney Co. U.S. District Judge Richard Leon on Tuesday approved AT&T's buyout of Time Warner, rebuffing an attempt by U.S. President Donald Trump to block the takeover and potentially clearing the path for more such deals in a rapidly changing media industry.
The two pursued the deal in part due to new competition from video streaming services like Netflix and Amazon. The federal court's decision to factor in the impact of new technology as a viable competitive threat allows dealmakers in industries outside of media to breath a sigh of relief.
Court approval of the AT&T-Time Warner deal now makes it more likely that similar kinds of pending mergers will go through — and there’s a good investing angle in this. The green light in the deal appears to clear the way for CVS Health’s (CVS) planned acquisition of insurer Aetna (AET), and Cigna’s (CI) pending takeover of pharmacy-benefit manager (PBM) Express Scripts (ESRX).
A federal judge's ruling late Tuesday blessing the AT&T-Time Warner merger raised hopes that the CVS-Aetna and Cigna-Express Scripts deals will win antitrust approval.
Health insurers and pharmacy-benefit managers with a rash of billion-dollar deals on the line are likely breathing sighs of relief after AT&T Inc. won clearance to takeover Time Warner Inc. The long-awaited green-light bodes well for CVS Health Corp.’s proposed $68 billion acquisition of health insurer Aetna Inc. and Cigna Corp.’s $54 billion deal for Express Scripts Holding Co., according to analysts. Investors were concerned the tie-ups may be challenged by the U.S. Department of Justice as both mergers received “second request” notifications, Matt Borsch, an analyst at BMO Capital Markets, wrote in a note to clients.
Shares of CVS Health jump after a federal judge allows AT&T's bid for Time Warner to go forward. The ruling is seen as a tacit go-ahead for so-called vertical mergers. CVS Health confirmed the pending deal for Aetna in December, a transaction valued at $69 billion.
U.S. Health and Human Services Secretary Alex Azar told lawmakers that it may be time to eliminate the complex system of rebates that drug companies and pharmacy-benefit managers use to negotiate and set prices. Once drugmakers set a list price for a product, pharmacy-benefit managers like CVS Health Corp. and Express Scripts Holding Co. negotiate rebates. The PBMs have been criticized for keeping some of the rebates for themselves instead of passing them directly to consumers to lower their out-of-pocket costs.
Kathryn Quinn, a nurse practitioner, right, administers a flu shot a MinuteClinic facility inside a CVS store in Wyckoff, New Jersey, on Sept. 1, 2009. Nurse practitioners are more in demand than all but two categories of physicians as large health providers like UnitedHealth Group’s Optum, CVS Health and insurers work with retailers to reach patients in their communities. , according to the 2018 snapshot into the U.S. healthcare workforce from MerrittHawkins, a subsidiary of AMN Healthcare. The report, released Tuesday by physician staffing firm MerrittHawkins and its parent AMN Healthcare, tracks the more than 3,000 physician and advanced practitioner recruiting assignments the firm conducted from April 1, 2017 to March 31, 2018.
CVS Health (CVS) significantly advances more than halfway through its 2019 renewals. Also, strong year-over-year Retail/LTC comparisons are encouraging.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
“Why CVS Loves ObamaCare” (Review & Outlook, May 30) paints a distorted view of the services CVS Health delivers for managed-care organizations, like the Ohio Medicaid program, and of our relationship with independent pharmacies in our network. The claim that we seek to drive independent pharmacies out of business is false. The vast majority of independent pharmacies belong to organizations that collectively negotiate reimbursements and discounts, including price adjustments after they invoice, with manufacturers and PBMs, allowing them to exert a significant competitive force in the market.
A top antitrust official at the U.S. Justice Department attempted to reassure investors on Thursday that worries that regulators would crack down on proposed combinations of two companies on a supply chain -- known as vertical mergers -- were overblown. Makan Delrahim, the assistant attorney general for antitrust, said that most proposed transactions were either good for consumers or neutral. "I understand that some journalists and observers have recently expressed concern that the antitrust division no longer believes that vertical mergers can be efficient and beneficial to competition and consumers," he said.
The two companies -- which are set to combine in a $77 billion merger once clearing regulatory reviews -- announced a slew of executive positions at the new, combined entity on Wednesday. Among the announcements was that Shawn Guertin, CFO of Aetna, would take over as CFO of CVS Health while Karen Lynch, currently president of Aetna, will take the executive vice president role at CVS Health while remaining president of the insurer. Fran Soistman will continue on as EVP and Head of Government Services for Aetna.
VA Mission Act Received Bipartisan Support and Signed into Law by President Trump WOONSOCKET, R.I. , June 6, 2018 /PRNewswire/ -- CVS Health (NYSE: CVS) today applauded the enactment of the VA Mission ...
The CVS logo is seen infront of one of its stores in Washington, DC on December 3, 2017. US pharmacy chain CVS has agreed to buy medical insurer Aetna for around $69 billion. CVS Health Wednesday introduced its new management team that will lead the larger company after it merges with Aetna, elevating Aetna’s top financial officer to CFO of the larger new company while keeping the pharmacy chain’s top doctor and pharmacy benefit executive.